This website is for informational and educational purposes only. Please do not self-medicate; contact a medical professional for advice before administration. This website is for informational and educational purposes only. Please do not self-medicate; contact a medical professional for advice before administration.

Pentazocine

PubChem CID: 441278

Connections displayed (default: 10).
Loading graph...

Compound Synonyms pentazocine, L-pentazocine, Pentazocin, Pentazocine, (-)-, 359-83-1, Levopentazocine, Pentazocinum, Pentazocine, L-, (-)-PENTAZOCINE, 7488-49-5, dl-Pentazocine, cis-(-)-Pentazocine, Fortalin, Pentagin, Sosigon, (-)-cis-Pentazocine, Pentazocine 2R,6R,11R-form, (-)-alpha-Pentazocine, UNII-768DQ5A5AI, Pentazocaine, Pentazocina, Pentazocine 2R,6R,11R-form [MI], Sosegon, 768DQ5A5AI, RP4A60D26L, WIN-20228, II-C-2, WIN 20,228, (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol, 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-, (2R,6R,11R)-, 2-(3,3-Dimethylallyl)cyclazocine, NIH 7958, WIN 20228, KF-1820, Pentazocine civ, Pentazocina [DCIT], (+)-Pentazocine, 2-Dimethylallyl-5,9-dimethyl-2'-hydroxybenzomorphan, Pentazocinum [INN-Latin], (1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol, (2R,6R,11R)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-2,6-methano-3-benzazocin-8-ol, (2R,6R,11R)-6,11-dimethyl-3-(3-methylbut-2-en-1-yl)-1,2,3,4,5,6-hexahydro-2,6-methanobenzo[d]azocin-8-ol, 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-, (2R,6R,11R)-rel-, Fortral (TN), 2'-Hydroxy-5,9-dimethyl-2-(3,3-dimethylallyl)-6,7-benzomorphan, PENTAZOCINE (+), PENTAZOCINE (-), 2-(3,3-Dimethylallyl)-2',2'-hydroxy-5,9-dimethyl-6,7-benzomorphan, 1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol, 3-(3-Methyl-2-butenyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol, UNII-RP4A60D26L, NIH-7958, HSDB 3150, 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, EINECS 206-634-6, (+-)-Pentazocine, (+/-)-pentazocine, NSC 107430, Pentazocine,(+/-), Pentazocine [USAN:USP:INN:BAN:JAN], cis-(+-)-Pentazocine, PENTAZOCINE [MI], cis-(+/-)-Pentazocine, PENTAZOCINE [INN], PENTAZOCINE [JAN], PENTAZOCINE [HSDB], PENTAZOCINE [USAN], CHEMBL560, PENTAZOCINE [VANDF], SCHEMBL2492, PENTAZOCINE [MART.], PENTAZOCINE [WHO-DD], CHEBI:7982, GTPL1606, 359-83-1 (free base), Pentazocine (JP18/USP/INN), DTXSID7023433, PENTAZOCINE [EP IMPURITY], PENTAZOCINE CIV [USP-RS], VOKSWYLNZZRQPF-GDIGMMSISA-N, (-)-.ALPHA.-PENTAZOCINE, PENTAZOCINE [EP MONOGRAPH], Pentazocine (1mg/ml in Methaniol), PENTAZOCINE [USP MONOGRAPH], (2R,6R,11R)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol, (6R,11S)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol, 6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol, EINECS 244-593-6, BDBM50001028, DB00652, FP26817, FP26819, (2alpha,6alpha,11R*)-(1)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methylbut-2-enyl)-2,6-methano-3-benzazocin-8-ol, (2R,6R,11R)-6,11-dimethyl-3-(3-methylbut-2-en-1-yl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol, 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, (2alpha,6alpha,11R*)-, NS00010467, C07421, D00498, Q415793, (-)-cis-Pentazocine, 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-, (2R,6R,11R)-, 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, (2R,6R,11R)- (9CI), 2,6-Methano-3-benzazocin-8-ol, 1,2, (1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-en-1-yl)-10-azatricyclo[7.3.1.0?,?]trideca-2(7),3,5-trien-4-ol, (1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-en-1-yl)-10-azatricyclo[7.3.1.0^{2,7}]trideca-2,4,6-trien-4-ol, (2R,6R,11R)-rel-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-2,6-methano-3-benzazocin-8-ol, Fortalgesic, Fortalin, 2,6-METHANO-3-BENZAZOCIN-8-OL, 1,2,3,4,5,6-HEXAHYDRO-6,11-DIMETHYL-3-(3-METHYL-2-BUTENYL)-, (2R,6R,11R)-, 2,6-METHANO-3-BENZAZOCIN-8-OL, 1,2,3,4,5,6-HEXAHYDRO-6,11-DIMETHYL-3-(3-METHYL-2-BUTENYL)-, CIS-(-)-, 6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol(Pentazocine), rel-(2R,6R,11R)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol
Topological Polar Surface Area 23.5
Hydrogen Bond Donor Count 1.0
Heavy Atom Count 21.0
Isotope Atom Count 0.0
Molecular Complexity 414.0
Database Name cmaup_ingredients;npass_chem_all;pubchem
Defined Atom Stereocenter Count 3.0
Uniprot Id Q60492, Q5BJF2, Q99720, P35372, P41145
Iupac Name (1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol
Prediction Hob 0.0
Target Id NPT296, NPT145, NPT272
Xlogp 3.3
Molecular Formula C19H27NO
Prediction Swissadme 1.0
Inchi Key VOKSWYLNZZRQPF-GDIGMMSISA-N
Fcsp3 0.5789473684210527
Logs -4.051
Rotatable Bond Count 2.0
Logd 3.815
Compound Name Pentazocine
Prediction Hob Swissadme 0.0
Exact Mass 285.209
Formal Charge 0.0
Monoisotopic Mass 285.209
Hydrogen Bond Acceptor Count 2.0
Molecular Weight 285.4
Covalent Unit Count 1.0
Total Atom Stereocenter Count 3.0
Total Bond Stereocenter Count 0.0
Esol -3.7744007714285717
Inchi InChI=1S/C19H27NO/c1-13(2)7-9-20-10-8-19(4)14(3)18(20)11-15-5-6-16(21)12-17(15)19/h5-7,12,14,18,21H,8-11H2,1-4H3/t14-,18+,19+/m0/s1
Smiles C[C@H]1[C@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
Nring 3.0
Defined Bond Stereocenter Count 0.0

  • 1. Outgoing r'ship FOUND_IN to/from Papaver Somniferum (Plant) Rel Props:Source_db:cmaup_ingredients;npass_chem_all